Nowcos Co., Ltd (XKON:257990)

CTI BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Aug 1, 2025	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Debt / Equity Ratio	2.05	2.05	5.24	3.35	3.02	0.90
Debt / EBITDA Ratio	4.02	4.02	340.52	9.17	-	3.11
Debt / FCF Ratio	3.39	3.39	-	89.55	-	-
Asset Turnover	1.34	1.34	1.12	1.03	1.09	1.45
Inventory Turnover	7.07	7.07	6.35	6.46	6.92	6.17
Quick Ratio	0.41	0.41	0.30	0.41	0.50	0.74
Current Ratio	0.72	0.72	0.59	0.77	0.91	1.21
Return on Equity (ROE)	28.96%	28.96%	-48.64%	-9.98%	-61.20%	26.70%
Return on Assets (ROA)	3.52%	3.52%	-2.84%	0.58%	-4.66%	4.85%
Return on Capital (ROIC)	5.93%	5.93%	-4.30%	0.81%	-6.58%	7.74%
Return on Capital Employed (ROCE)	13.10%	13.10%	-	1.70%	-	11.40%
Buyback Yield / Dilution	-28.89%	-0.01%	0.32%	-13.64%	-13.78%	-14.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.